What is the share price of Viyash Scientific Ltd (VIYASH) today?
The share price of VIYASH as on 11th February 2026 is ₹216.11. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Viyash Scientific Ltd (VIYASH) share?
The past returns of Viyash Scientific Ltd (VIYASH) share are- Past 1 week: 1.93%
- Past 1 month: 10.25%
- Past 3 months: -5.51%
- Past 6 months: 22.21%
- Past 1 year: 42.30%
- Past 3 years: 185.67%
- Past 5 years: -13.00%
What are the peers or stocks similar to Viyash Scientific Ltd (VIYASH)?
The peers or stocks similar to Viyash Scientific Ltd (VIYASH) include:What is the market cap of Viyash Scientific Ltd (VIYASH) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Viyash Scientific Ltd (VIYASH) is ₹8942.65 Cr as of 11th February 2026.What is the 52 week high and low of Viyash Scientific Ltd (VIYASH) share?
The 52-week high of Viyash Scientific Ltd (VIYASH) is ₹257.85 and the 52-week low is ₹117.35.What is the PE and PB ratio of Viyash Scientific Ltd (VIYASH) stock?
The P/E (price-to-earnings) ratio of Viyash Scientific Ltd (VIYASH) is 408.90. The P/B (price-to-book) ratio is 11.61.Which sector does Viyash Scientific Ltd (VIYASH) belong to?
Viyash Scientific Ltd (VIYASH) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Viyash Scientific Ltd (VIYASH) shares?
You can directly buy Viyash Scientific Ltd (VIYASH) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Viyash Scientific Ltd
VIYASH Share Price
216.115.41% (+11.10)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
VIYASH Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
VIYASH Performance & Key Metrics
VIYASH Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 76.45 | 11.61 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 35.88 | 5.67 | 0.60% |
VIYASH Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
VIYASH Company Profile
Viyash Scientific Ltd is an integrated pharmaceutical company operating globally with eight manufacturing facilities across India, Turkey, Brazil, Spain, and Germany, specializing in animal health APIs, finished dosage formulations, and analytical services for pharmaceutical, personal care, and nutraceutical sectors.
SUNPHARMA
PE Ratio
37.49
37.49
1Y Return
0.67%
0.67%
Buy Reco %
94.44
94.44
TORNTPHARM
PE Ratio
72.24
72.24
1Y Return
30.59%
30.59%
Buy Reco %
76.92
76.92
CIPLA
PE Ratio
20.56
20.56
1Y Return
7.11%
7.11%
Buy Reco %
56.25
56.25
DRREDDY
PE Ratio
18.49
18.49
1Y Return
5.00%
5.00%
Buy Reco %
51.61
51.61
LUPIN
PE Ratio
30.69
30.69
1Y Return
6.84%
6.84%
Buy Reco %
72.22
72.22
VIYASH Sentiment Analysis
VIYASH Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
VIYASH Stock Summary · February 2026
In the latest earnings call, the company showcased robust financial performance, with a 12% year-on-year revenue increase and a significant 64% growth in adjusted EBITDA, despite facing one-time merger-related costs. The successful integration of operations post-merger has established a solid revenue base, positioning the company for accelerated growth, particularly in the Animal Health sector, where strategic investments are enhancing market presence in Europe and India. Management remains optimistic about achieving a 20% EBITDA margin by 2028, supported by a strong focus on operational efficiency and cost control. Additionally, the company is exploring opportunities in the U.S. market while maintaining a cautious yet proactive approach to future investments, ensuring long-term sustainability and profitability.
VIYASH Stock Growth Drivers
VIYASH Stock Growth Drivers
8Strong Financial Performance
The company has reported significant financial achievements, including a revenue increase of 11% year-on-year in
Successful Merger Integration
The company has successfully integrated operations following the merger, achieving a minimum revenue base of
VIYASH Stock Challenges
VIYASH Stock Challenges
0
Hmm, looks like there are nochallenges
VIYASH Forecast
VIYASH Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
VIYASH
VIYASH
Income
Balance Sheet
Cash Flow
Annual Normal View
VIYASH Income Statement
VIYASH Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 694.65 | 1,292.62 | 1,047.98 | 1,189.33 | 1,369.98 | 1,423.67 | 1,427.30 | 1,395.45 | 1,570.34 | 2,578.80 | ||||||||||
Raw Materials | 366.89 | 486.44 | 570.52 | 600.59 | 733.68 | 842.41 | 814.87 | 789.20 | 829.94 | 2,149.09 | ||||||||||
| Power & Fuel Cost | 12.77 | 14.66 | 23.06 | 24.73 | 28.75 | 33.86 | 42.45 | 35.46 | 32.98 | |||||||||||
| Employee Cost | 106.22 | 113.83 | 145.95 | 165.06 | 187.22 | 231.37 | 258.39 | 250.57 | 281.12 | |||||||||||
| Selling & Administrative Expenses | 74.68 | 94.72 | 90.93 | 108.27 | 115.85 | 132.65 | 139.02 | 138.35 | 159.09 | |||||||||||
| Operating & Other expenses | 82.59 | 64.28 | 83.92 | 110.27 | 92.86 | 63.12 | 219.02 | 126.88 | 95.71 | |||||||||||
EBITDA | 51.50 | 518.69 | 133.60 | 180.41 | 211.62 | 120.26 | -46.45 | 54.99 | 171.50 | 429.71 | ||||||||||
| Depreciation/Amortization | 40.07 | 41.34 | 41.92 | 50.62 | 50.60 | 51.54 | 55.69 | 61.54 | 66.45 | 148.89 | ||||||||||
| PBIT | 11.43 | 477.35 | 91.68 | 129.79 | 161.02 | 68.72 | -102.14 | -6.55 | 105.05 | 280.82 | ||||||||||
| Interest & Other Items | 28.34 | 33.07 | 32.80 | 35.71 | 24.38 | 15.77 | 35.52 | 48.09 | 60.75 | 63.55 | ||||||||||
| PBT | -16.91 | 444.28 | 58.88 | 94.08 | 136.64 | 52.95 | -137.66 | -54.64 | 44.30 | 217.27 | ||||||||||
| Taxes & Other Items | -3.08 | 22.72 | 10.22 | 24.17 | 41.19 | 11.98 | -16.50 | -18.77 | 22.43 | 100.29 | ||||||||||
| Net Income | -13.83 | 421.56 | 48.66 | 69.91 | 95.45 | 40.97 | -121.16 | -35.87 | 21.87 | 116.98 | ||||||||||
| EPS | -0.53 | 15.98 | 1.91 | 2.82 | 3.84 | 1.65 | -4.87 | -1.44 | 0.88 | 4.67 | ||||||||||
| DPS | 0.00 | 0.18 | 0.20 | 0.00 | 0.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.01 | 0.10 | 0.00 | 0.13 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
VIYASH Company Updates
FY 2026FY 2026
Investor Presentation
Feb 6PDF
Nov 18PDF
Nov 17PDF
Nov 14PDF
VIYASH Stock Peers
VIYASH Past Performance & Peer Comparison
VIYASH Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Viyash Scientific Ltd | 408.90 | 11.61 | — |
| Sun Pharmaceutical Industries Ltd | 37.49 | 5.65 | 0.94% |
| Torrent Pharmaceuticals Ltd | 72.24 | 18.19 | 0.78% |
| Cipla Ltd | 20.56 | 3.46 | 1.19% |
VIYASH Stock Price Comparison
Compare VIYASH with any stock or ETFCompare VIYASH with any stock or ETF
VIYASH
VIYASH Holdings
VIYASH Shareholdings
VIYASH Promoter Holdings Trend
VIYASH Promoter Holdings Trend
Increased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has increased by 8.80%
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
VIYASH Institutional Holdings Trend
VIYASH Institutional Holdings Trend
Decreased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has decreased by 7.86%
Decreased Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has decreased by 2.74%
VIYASH Shareholding Pattern
VIYASH Shareholding Pattern
VIYASH Shareholding History
VIYASH Shareholding History
Foreign Institutions
Mutual Funds Invested in VIYASH
Mutual Funds Invested in VIYASH
No mutual funds holding trends are available
Top 5 Mutual Funds holding Viyash Scientific Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 5.1234% | Percentage of the fund’s portfolio invested in the stock 1.67% | Change in the portfolio weight of the stock over the last 3 months 0.01% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 14/118 (-1) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.3363% | Percentage of the fund’s portfolio invested in the stock 8.83% | Change in the portfolio weight of the stock over the last 3 months 0.11% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 4/38 (-1) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.2491% | Percentage of the fund’s portfolio invested in the stock 2.11% | Change in the portfolio weight of the stock over the last 3 months 0.38% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 19/46 (+5) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing VIYASH stock
smallcases containing VIYASH stock
Looks like this stock is not in any smallcase yet.
VIYASH Events
VIYASH Events
VIYASH Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
VIYASH Dividend Trend
No dividend trend available
VIYASH Upcoming Dividends
VIYASH Upcoming Dividends
No upcoming dividends are available
VIYASH Past Dividends
VIYASH Past Dividends
Cash Dividend
Ex DateEx DateSep 8, 2021
Final
Final | Div/Share: ₹0.50
Dividend/Share
₹0.50
Ex DateEx Date
Sep 8, 2021
Cash Dividend
Ex DateEx DateAug 21, 2019
Final
Final | Div/Share: ₹0.20
Dividend/Share
₹0.20
Ex DateEx Date
Aug 21, 2019
Cash Dividend
Ex DateEx DateNov 20, 2017
Interim
Interim | Div/Share: ₹0.20
Dividend/Share
₹0.20
Ex DateEx Date
Nov 20, 2017
Cash Dividend
Ex DateEx DateSep 16, 2011
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Sep 16, 2011
Cash Dividend
Ex DateEx DateSep 23, 2010
Final
Final | Div/Share: ₹2.00
Dividend/Share
₹2.00
Ex DateEx Date
Sep 23, 2010
VIYASH Stock News & Opinions
VIYASH Stock News & Opinions
Articles & Videos
Earnings
Viyash Scientific consolidated net profit declines 13.83% in the December 2025 quarter
Net profit of Viyash Scientific declined 13.83% to Rs 38.44 crore in the quarter ended December 2025 as against Rs 44.61 crore during the previous quarter ended December 2024. Sales rose 10.90% to Rs 858.41 crore in the quarter ended December 2025 as against Rs 774.03 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales858.41774.03 11 OPM %20.4612.89 - PBDT172.8685.76 102 PBT114.3327.37 318 NP38.4444.61 -14 Powered by Capital Market - Live
5 days agoCapital Market - Live
Corporate
Sequent Scientific to declare Quarterly Results
Sequent Scientific will hold a meeting of the Board of Directors of the Company on 5 February 2026.Powered by Capital Market - Live
2 weeks agoCapital Market - Live
Earnings
Sequent Scientific consolidated net profit rises 464.75% in the September 2025 quarter
Net profit of Sequent Scientific rose 464.75% to Rs 14.74 crore in the quarter ended September 2025 as against Rs 2.61 crore during the previous quarter ended September 2024. Sales rose 15.01% to Rs 423.99 crore in the quarter ended September 2025 as against Rs 368.65 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales423.99368.65 15 OPM %13.1310.61 - PBDT44.3229.32 51 PBT28.8612.22 136 NP14.742.61 465 Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Sequent Scientific allots 11,86,700 equity shares under ESOP
Sequent Scientific has allotted 11,86,700 equity shares under ESOP on 11 November 2025. Consequent to the allotment of the aforesaid equity shares, the issued and the paid-up equity share capital of the Company will increase from Rs. 50,35,25,296 consisting of 25,17,62,648 equity shares of Rs. 2 each to Rs. 50,58,98,696 consisting of 25,29,49,348 equity shares of Rs. 2 each.Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Sequent Scientific to hold board meeting
Sequent Scientific will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live
3 months agoCapital Market - Live
Earnings
Sequent Scientific consolidated net profit rises 119.82% in the June 2025 quarter
Net profit of Sequent Scientific rose 119.82% to Rs 14.31 crore in the quarter ended June 2025 as against Rs 6.51 crore during the previous quarter ended June 2024. Sales rose 13.12% to Rs 441.42 crore in the quarter ended June 2025 as against Rs 390.21 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales441.42390.21 13 OPM %11.8210.75 - PBDT41.9028.25 48 PBT26.7712.00 123 NP14.316.51 120 Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Sequent Scientific to convene board meeting
Sequent Scientific will hold a meeting of the Board of Directors of the Company on 8 August 2025.Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Sequent Scientific to conduct EGM
Sequent Scientific announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 26 August 2025.Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Sequent Scientific schedules EGM
Sequent Scientific announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 30 August 2025.Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Sequent Scientific schedules AGM
Sequent Scientific announced that the 40th Annual General Meeting(AGM) of the company will be held on 8 August 2025.Powered by Capital Market - Live
6 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 5.72%, vs industry avg of 10.04%
Over the last 5 years, market share decreased from 0.47% to 0.37%
Over the last 5 years, net income has grown at a yearly rate of -20.74%, vs industry avg of 20.02%